A Phase 1, Randomized, Placebo-Controlled, Ascending Cohort, Dose Escalation Study in Normal Healthy Volunteers

Clinical trial NCT02727283 · COMPLETED

Trial details

NCT number: NCT02727283
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Irritable Bowel Syndrome

Start date: 2015-11-26
Primary completion: 2016-03-18
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.